Profile | GDS2987 / GI_13775185-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 6.8 | 25 |
GSM215244 | HMVEC_vehicle_rep2 | 13.4 | 33 |
GSM215253 | HMVEC_vehicle_rep3 | 3 | 11 |
GSM215254 | HMVEC_atorvastatin_rep1 | 5.6 | 16 |
GSM215282 | HMVEC_atorvastatin_rep3 | 14.9 | 34 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 25.5 | 44 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 8.8 | 18 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | 23.3 | 43 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 16.1 | 25 |
GSM215298 | PASMC_vehicle_rep2 | 16.6 | 26 |
GSM215310 | PASMC_vehicle_rep3 | 28.4 | 42 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 18.5 | 29 |
GSM215313 | PASMC_atorvastatin_rep3 | 17.9 | 27 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 29.9 | 45 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 15.2 | 29 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 17 | 29 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 4.6 | 9 |
GSM215329 | PASMC_SLx2119_rep3 | 14.7 | 28 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 4 | 12 |
GSM215332 | Fibroblasts_vehicle_rep3 | ||
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 13.3 | 35 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 18.1 | 41 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 6.9 | 23 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 9.4 | 30 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 31.7 | 61 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 8.5 | 25 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 0.2 | 0 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 41.5 | 65 |